On November 24, 2021, the Omicron variant (B. 1. 1. 529) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported to the World Health Organization (WHO) from South Africa. The Omicron variant has joined several other SARS-CoV-2 variants as a fear variant (VOC), indicating that this strain is linked to increased transmissibility and virulence, as well as the ability to decrease the effectiveness of public fitness and social measures. as well as having diagnostics, vaccines and treatments.
According to the WHO, the first SARS-CoV-2 infection with the Omicron variant occurred from a pattern collected on November 9, 2021. However, in recent weeks, the number of coronavirus disease 2019 (COVID-19) cases in Africa has risen sharply, with an increasing number of positive cases for the Omicron variant of SARS-CoV-2.
While the number of cases in South Africa remains low, with 2,828 cases reported on Friday, November 26, 2021, the speed at which the Omicron variant appears to be infecting young South Africans is causing increased fear among fitness professionals in that country. Rudo Mathivha, head of the intensive care unit at Soweto’s Baragwanath Hospital, said a much younger population of patients in their 20s and 30s are admitted to the hospital with moderate to severe illnesses, with some of those patients requiring intensive care.
Notably, about 36% of South Africa’s adult population has been vaccinated against COVID-19. To that end, about 65% of newly admitted South African patients are unvaccinated, while Mathivha says the maximum of the remaining patients have received one dose of COVID-19 vaccines.
Since its initial identification, researchers have discovered that the Omicron variant of SARS-CoV-2 has a giant number of mutations, adding more than 30 tweaks to the spike protein. Importantly, the SARS-CoV-2 spike protein, the ultimate target of existing COVID-19 vaccines, play a critical role in how the virus recognizes host cells and enters them.
Of the 30 mutations in the spike protein, ten of those mutations were known in the angiotensin-converting enzyme 2 (ACE2) receptor. This is comparable to the number of mutations that have been discovered in this protein in SARS-CoV-2 variants such as the Delta and Beta variants, which have two and 3 mutations in this protein, respectively.
Although the available data on the significance of those mutations is limited, it is vital to note that all mutations known to affect the transmissibility of the virus are known in the genome of the Omicron variant. In addition, the E484A mutation has been identified. known in the Omicron variant, which is at the site that elegance 2 antibodies can recognize, raising concerns that this variant could evade the action of human antibodies opposed to SARS-CoV-2. Due to this combination of mutations, the researchers suspected that the Omicron variant would possibly be able to cut off the neutralizing movements provoked through immune responses generated through infections and/or vaccines passed by SARS-CoV-2.
The cases of SARS-CoV-2 Omicron appear, first of all, to be limited to a cluster of infections among some university academics in Pretoria. However, this group spread quickly: hundreds, then thousands, of other people were infected in Pretoria and, soon after, in Johannesburg, the country’s largest city.
Recent diagnostic tests indicate that the Omicron variant could account for up to 90% of new cases in South Africa. Furthermore, some early studies have suggested that this variant has a reproduction rate of two, which indicates that each person infected with the Omicron variant is likely to spread it to two other people.
In addition to South Africa, researchers also detected the Omicron variant in Botswana, Hong Kong, Belgium, Israel, Germany, Great Britain, the Czech Republic, Austria and Italy. As the variant appears to spread around the world, thirteen more cases have been known in the Netherlands, two in Australia and two in Denmark. Notably, the thirteen known cases in Amsterdam, Netherlands, were detected among other people on board two flights from South Africa on Friday, November 26. This was also the case with the known cases in Denmark and Australia, which were known in travelers arriving from the South. Africa.
One of the first countries to react to the emergence of the Omicron variant is Israel, which announced on November 27, 2021, that, with government approval, all foreigners would be banned from entering the country for at least 14 days. Reintroduce anti-terrorism phone tracking technologies to help the government prevent the spread of this variant.
Similarly, the British government recently announced that they would also enforce certain measures to contain the spread of the Omicron variant. These measures will include stricter testing policies for foreigners arriving in Britain, as well as requiring mask-wearing in certain settings.
The United States also announced that they would suspend the entry of foreigners into the United States who are traveling from Botswana, Eswatini, Lesotho, Malawi, Mozambique, Namibia, South Africa, and Zimbabwe. In addition, the European Union has also agreed to introduce similar temporary restrictions on all travel from southern African nations in an effort to prevent the entry of the Omicron variant into this continent.
Despite the intent of those travel restrictions, several prominent public health officials have criticized those measures, noting that the Omicron variant has already been detected on three other continents.
While existing reports on the Omicron variant have raised significant considerations about the ability of existing vaccines to protect Americans from reinfection, it should be noted that those studies are incredibly limited due to the novelty of this new strain. As a result, many more studies are needed. There is a need to fully understand how the emergence of the Omicron variant will affect the trajectory of the COVID-19 pandemic.
Written by
Use one of the following to cite this article in your essay, article, or report:
APPLICATION
Cuffari, Bénédette. (2023, April 06). Omicron variant of SARS-CoV-2: what we know so far. Retrieved December 9, 2023, https://www. news-medical. net/news/20211128/SARS-CoV-2-Omicron-variant -What-We-Know-So Far. aspx.
Deputy
Cuffari, Bénédette. SARS-CoV-2 Omicron Variant: What We Know So Far”. News-Medical. December 9, 2023.
Chicago
Cuffari, Benedette. “SARS-CoV-2 Omicron variant: What we know so far”. News-Medical. https://www.news-medical.net/news/20211128/SARS-CoV-2-Omicron-variant-What-we-know-so-far.aspx. (accessed December 09, 2023).
Harvard
Cuffari, Bénédette. 2023. SARS-CoV-2 Omicron variant: what we know so far. News-Medical, retrieved December 9, 2023, https://www. news-medical. net/news/20211128/SARS-CoV-2-Omicron-variant-What-we-know-so far. aspx.
News-Medical. net – An AZoNetwork site
Owned and operated by AZoNetwork, © 2000-2023